Enabling Biotechnologies

Enabling Biotechnologies is a biotechnology company specializing in the rapid, automated synthesis of complex biomolecules, including peptides and proteins. Founded on technology developed in the Pentelute Lab at MIT, the company utilizes high-speed flow chemistry to significantly reduce the time required for chemical synthesis from days to minutes. Their platform enables the production of long, difficult-to-synthesize peptides and small proteins with high purity. This technology supports drug discovery, personalized medicine, and the development of novel therapeutic modalities. By streamlining the synthesis process, Enabling Biotechnologies aims to accelerate the transition from molecular design to functional testing.